
Sign up to save your podcasts
Or
In this episode of CTSNet’s flagship podcast, editor in chief Joel Dunning interviews Dr. Michael Mack. Dr. Mack, of Baylor Healthcare System, is the first author of the PARTNER 3 trial, which recently published its five-year results. They talk about the outcomes of the trial and what they mean for the future of TAVR.
Items Mentioned
Disclaimer
The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.
4.6
88 ratings
In this episode of CTSNet’s flagship podcast, editor in chief Joel Dunning interviews Dr. Michael Mack. Dr. Mack, of Baylor Healthcare System, is the first author of the PARTNER 3 trial, which recently published its five-year results. They talk about the outcomes of the trial and what they mean for the future of TAVR.
Items Mentioned
Disclaimer
The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.
131 Listeners
43,969 Listeners
90,949 Listeners
32,291 Listeners
325 Listeners
161 Listeners
1,301 Listeners
865 Listeners
2,433 Listeners
111,917 Listeners
56,231 Listeners
16,863 Listeners
31 Listeners
43 Listeners
2 Listeners